¼¼°èÀÇ ½ÉÀå ¸ÅÇÎ ½ÃÀå º¸°í¼­(2025³â)
Cardiac Mapping Global Market Report 2025
»óǰÄÚµå : 1703063
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,342,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,167,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,992,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÉÀå ¸ÅÇÎ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö CAGR 7.3%·Î 32¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, °í·ÉÈ­ Àα¸ Áõ°¡, ÀÎ½Ä °³¼± ¹× °ËÁø ÇÁ·Î±×·¥, ÀÇ·á ÀÎÇÁ¶ó °³¼±, °Ç°­ ¹®Á¦ À¯º´·ü Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÀΰøÁö´É(AI)°úÀÇ ÅëÇÕ, ½Ç½Ã°£ 3D ¸ÅÇÎ ½Ã½ºÅÛ, Ä«Å×ÅÍ ±â¼ú Çâ»ó, Ŭ¶ó¿ìµå ±â¹Ý µ¥ÀÌÅÍ ºÐ¼®, Àü±â»ý¸®ÇÐ ¼ÒÇÁÆ®¿þ¾îÀÇ °­È­ µîÀÌ ÀÖ½À´Ï´Ù.

½ÉÀå ¸ÅÇÎ ½ÃÀåÀº ºÎÁ¤¸Æ, ½ÉÀ帶ºñ, ½ÉºÎÀü µîÀÇ ÇÕº´ÁõÀ» À¯¹ßÇÏ°í ½ÉÀåÀÇ ±¸Á¶¿Í ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ ÁúȯÀ» Æ÷ÇÔÇÑ ½ÉÀå ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÁÂ½Ä »ýȰ½À°ü, ½Ä»ýȰÀÇ º¯È­, Àα¸ÀÇ °í·ÉÈ­ µîÀÌ ÀÌ·¯ÇÑ ÁúȯÀÇ ¹ß»ý·ü Áõ°¡¿¡ ÇÑ ¸òÀ» Çϰí ÀÖ½À´Ï´Ù. ½ÉÀå ¸ÅÇÎÀº ½ÉÀå ¸®µëÀÇ Àü±âÀû ÀÌ»óÀ» Á¤È®ÇÏ°Ô ÆÄ¾ÇÇÔÀ¸·Î½á ½ÉÀå ÁúȯÀÇ Áø´Ü°ú Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¿µ±¹ ½ÉÀåÀç´Ü(British Heart Foundation)Àº 2024³â 1¿ù ¿µ±¹¿¡¼­ 100¸¸ ¸í ÀÌ»óÀÌ ½ÉºÎÀüÀ¸·Î °íÅë ¹Þ°í ÀÖÀ¸¸ç, ¸Å³â ¾à 20¸¸ ¸íÀÌ »õ·Î Áø´ÜµÇ°í ¾à 73¸¸ ¸íÀÌ GP ½ÉºÎÀü µî·Ï¿¡ Æ÷ÇԵǾî ÀÖ´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ´Â ½ÉÀå ÁúȯÀÇ È®»êÀÌ ½ÉÀå ¸ÅÇÎ ½ÃÀåÀÇ ¼ºÀåÀ» ¾î¶»°Ô ÃËÁøÇϰí ÀÖ´ÂÁö¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÉÀå ¸ÅÇÎ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº Áø´Ü Á¤È®µµ¿Í Ä¡·á È¿°ú¸¦ Çâ»ó½Ã۱â À§ÇØ ½ÉÀå ¸ÅÇÎ Ç÷§Æû°ú °°Àº ÷´Ü ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀº ½ÉÀå ³» Àü±âÀû Ȱµ¿À» ½Ã°¢È­ ¹× ºÐ¼®Çϴ ÷´Ü ±â¼úÀ» äÅÃÇÏ¿© ºÎÁ¤¸Æ µîÀÇ Áø´Ü ¹× Ä¡·á¿¡ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ÇコÄÉ¾î ±â¾÷ ¾Öº¸Æ® ·¡¹ö·¯Å丮½º(Abbott Laboratories)´Â 2022³â 1¿ù EnSite X EP ½Ã½ºÅÛ¿¡ ´ëÇÑ FDA 510(k) ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. ÀÌ Ç÷§ÆûÀº Ä«Å×ÅÍÀÇ ¹æÇâ¿¡ °ü°è¾øÀÌ Á¾ÇÕÀûÀÎ 360µµ ºä¸¦ Á¦°øÇÏ´Â »ó¼¼ÇÑ 3D ¸ÊÀ» »ý¼ºÇÏ¿© Àǻ簡 ºñÁ¤»óÀûÀÎ ½ÉÀå ¸®µëÀÇ ±â¿øÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¾Öº¸Æ® °íÀ¯ÀÇ EnSite Omnipolar Technology(OT)¿Í ¾îµå¹ÙÀÌÀúÀÇ HD ±×¸®µå Ä«Å×ÅÍ(HD Grid Catheter)¸¦ Ȱ¿ëÇÏ¿© ¾î¶² Ä«Å×ÅÍ °¢µµ¿¡¼­µµ Á¤È®ÇÑ ÀüÀ§µµ(electrograph)¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Cardiac mapping involves creating a detailed representation of the heart's electrical activity to pinpoint abnormal rhythms (arrhythmias) by mapping the location and patterns of electrical impulses. This data is essential for diagnosing and treating various cardiac conditions and guiding procedures such as ablation therapy to correct irregular heartbeats.

The primary types of cardiac mapping systems are contact cardiac mapping and non-contact cardiac mapping. Contact cardiac mapping systems utilize electrodes in direct contact with heart tissue to precisely identify and map electrical activity. They are used for diagnosing and treating conditions such as atrial fibrillation, atrial flutter, and atrioventricular nodal reentrant tachycardia (AVNRT). These systems are employed by hospitals, clinics, diagnostic centers, and other healthcare facilities.

The cardiac mapping research report is one of a series of new reports from The Business Research Company that provides cardiac mapping market statistics, including the cardiac mapping industry's global market size, regional shares, competitors with a cardiac mapping market share, detailed cardiac mapping market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac mapping industry. This cardiac mapping market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac mapping market size has grown strongly in recent years. It will grow from $2.3 billion in 2024 to $2.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to the introduction of catheter ablation, development of 3D mapping systems, improvements in imaging technologies, rise in the prevalence of cardiac arrhythmias, and growth in minimally invasive procedures.

The cardiac mapping market size is expected to see strong growth in the next few years. It will grow to $3.29 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, growing aging population, rising awareness and screening programs, improved healthcare infrastructure, and rising prevalence of health issues. Major trends in the forecast period include integration with artificial intelligence (AI), real-time 3D mapping systems, improved catheter technologies, cloud-based data analysis, and enhanced electrophysiology software.

The cardiac mapping market is poised for growth due to increasing prevalence of heart ailments, which encompass various conditions affecting the heart's structure and function, leading to complications such as arrhythmias, heart attacks, and heart failure. Sedentary lifestyles, poor dietary habits, and aging populations contribute to the rising incidence of these ailments. Cardiac mapping plays a crucial role in diagnosing and treating heart conditions by precisely identifying electrical abnormalities in the heart's rhythm. For example, the British Heart Foundation reported in January 2024 that over one million individuals in the UK suffer from heart failure, with approximately 200,000 new cases diagnosed annually and around 730,000 people included in GP heart failure registers. This underscores how the prevalence of heart ailments is fueling growth in the cardiac mapping market.

Leading companies in the cardiac mapping market are focusing on developing advanced solutions such as cardiac mapping platforms to improve diagnostic precision and treatment effectiveness. These platforms employ sophisticated technologies to visualize and analyze electrical activity within the heart, aiding in the diagnosis and treatment of cardiac arrhythmias and other conditions. For instance, Abbott Laboratories, a US-based healthcare company, received FDA 510(k) clearance in January 2022 for its EnSite X EP system. This platform helps physicians pinpoint origins of abnormal heart rhythms by generating detailed 3D maps that offer a comprehensive 360-degree view, regardless of catheter orientation. The system utilizes Abbott's proprietary EnSite omnipolar technology (OT) and advisor HD grid catheter to capture accurate electrograms from any catheter angle.

In August 2022, Medtronic Plc, a US-based medical technology firm, acquired Affera Inc. for $925 million. This acquisition expands Medtronic's cardiac ablation portfolio to include Affera's advanced cardiac mapping and navigation platform, alongside its diagnostic and therapeutic catheters. Affera Inc., based in the US, specializes in developing systems for cardiac mapping and ablation.

Major companies operating in the cardiac mapping market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., GE Healthcare Technologies, Boston Scientific Corporation, Epmap-System, APN Health LLC, BIOTRONIK SE & Co. KG, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Biosense Webster Inc., BioSig Technologies Inc., CardioFocus Inc., Kardium Inc., Acutus Medical Inc., Navix Medical Ltd., EP Solutions SA, CoreMap Inc., Catheter Precision Inc.

North America was the largest region in the cardiac mapping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac mapping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac mapping market consists of revenues earned by entities by providing services such as monitoring and follow-up, diagnostic mapping, and ablation guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac mapping market also includes sales of electrophysiology mapping systems, mapping software, navigation systems, and ablation catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Mapping Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac mapping market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cardiac mapping ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac mapping market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Cardiac Mapping Market Characteristics

3. Cardiac Mapping Market Trends And Strategies

4. Cardiac Mapping Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac Mapping Growth Analysis And Strategic Analysis Framework

6. Cardiac Mapping Market Segmentation

7. Cardiac Mapping Market Regional And Country Analysis

8. Asia-Pacific Cardiac Mapping Market

9. China Cardiac Mapping Market

10. India Cardiac Mapping Market

11. Japan Cardiac Mapping Market

12. Australia Cardiac Mapping Market

13. Indonesia Cardiac Mapping Market

14. South Korea Cardiac Mapping Market

15. Western Europe Cardiac Mapping Market

16. UK Cardiac Mapping Market

17. Germany Cardiac Mapping Market

18. France Cardiac Mapping Market

19. Italy Cardiac Mapping Market

20. Spain Cardiac Mapping Market

21. Eastern Europe Cardiac Mapping Market

22. Russia Cardiac Mapping Market

23. North America Cardiac Mapping Market

24. USA Cardiac Mapping Market

25. Canada Cardiac Mapping Market

26. South America Cardiac Mapping Market

27. Brazil Cardiac Mapping Market

28. Middle East Cardiac Mapping Market

29. Africa Cardiac Mapping Market

30. Cardiac Mapping Market Competitive Landscape And Company Profiles

31. Cardiac Mapping Market Other Major And Innovative Companies

32. Global Cardiac Mapping Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Mapping Market

34. Recent Developments In The Cardiac Mapping Market

35. Cardiac Mapping Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â